Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Supplemental material
  • Version history
  • Article usage
  • Citations to this article
Advertisement

ResearchIn-Press PreviewCardiologyVascular biology Open Access | 10.1172/jci.insight.203575

GLS1 governs vascular smooth muscle cell phenotypic switching and aortic dissection via glutamate metabolism

Wei Xie,1 Chen Ning,2 Chen Lu,1 Dongjin Wang,3 Shuang Zhao,4 Tianyu Song,5 and Hailong Cao1

1Department of Cardiac Surgery, Southeast University, Nanjing, China

2School of Pharmacy, Nanjing Medical Unicersity, Nanjing, China

3Department of Cardiac Surgery, Nanjing Medical Unicersity, Nanjing, China

4School of Pharmacy, Nanjing Medical University, Nanjing, China

5School of Medicine, Nanjing University of Chinese Medicine, Nanjing, China

Find articles by Xie, W. in: PubMed | Google Scholar

1Department of Cardiac Surgery, Southeast University, Nanjing, China

2School of Pharmacy, Nanjing Medical Unicersity, Nanjing, China

3Department of Cardiac Surgery, Nanjing Medical Unicersity, Nanjing, China

4School of Pharmacy, Nanjing Medical University, Nanjing, China

5School of Medicine, Nanjing University of Chinese Medicine, Nanjing, China

Find articles by Ning, C. in: PubMed | Google Scholar

1Department of Cardiac Surgery, Southeast University, Nanjing, China

2School of Pharmacy, Nanjing Medical Unicersity, Nanjing, China

3Department of Cardiac Surgery, Nanjing Medical Unicersity, Nanjing, China

4School of Pharmacy, Nanjing Medical University, Nanjing, China

5School of Medicine, Nanjing University of Chinese Medicine, Nanjing, China

Find articles by Lu, C. in: PubMed | Google Scholar

1Department of Cardiac Surgery, Southeast University, Nanjing, China

2School of Pharmacy, Nanjing Medical Unicersity, Nanjing, China

3Department of Cardiac Surgery, Nanjing Medical Unicersity, Nanjing, China

4School of Pharmacy, Nanjing Medical University, Nanjing, China

5School of Medicine, Nanjing University of Chinese Medicine, Nanjing, China

Find articles by Wang, D. in: PubMed | Google Scholar

1Department of Cardiac Surgery, Southeast University, Nanjing, China

2School of Pharmacy, Nanjing Medical Unicersity, Nanjing, China

3Department of Cardiac Surgery, Nanjing Medical Unicersity, Nanjing, China

4School of Pharmacy, Nanjing Medical University, Nanjing, China

5School of Medicine, Nanjing University of Chinese Medicine, Nanjing, China

Find articles by Zhao, S. in: PubMed | Google Scholar

1Department of Cardiac Surgery, Southeast University, Nanjing, China

2School of Pharmacy, Nanjing Medical Unicersity, Nanjing, China

3Department of Cardiac Surgery, Nanjing Medical Unicersity, Nanjing, China

4School of Pharmacy, Nanjing Medical University, Nanjing, China

5School of Medicine, Nanjing University of Chinese Medicine, Nanjing, China

Find articles by Song, T. in: PubMed | Google Scholar

1Department of Cardiac Surgery, Southeast University, Nanjing, China

2School of Pharmacy, Nanjing Medical Unicersity, Nanjing, China

3Department of Cardiac Surgery, Nanjing Medical Unicersity, Nanjing, China

4School of Pharmacy, Nanjing Medical University, Nanjing, China

5School of Medicine, Nanjing University of Chinese Medicine, Nanjing, China

Find articles by Cao, H. in: PubMed | Google Scholar

Published April 23, 2026 - More info

JCI Insight. https://doi.org/10.1172/jci.insight.203575.
Copyright © 2026, Xie et al. This work is licensed under the Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
Published April 23, 2026 - Version history
View PDF
Abstract

Aortic dissection (AD) is a catastrophic vascular emergency with high mortality, and current pharmacologic interventions to prevent its progression are limited. Vascular smooth muscle cells (VSMCs) undergo a pathological phenotypic switch from a contractile to a synthetic state during AD, compromising aortic wall integrity; however, the underlying metabolic mechanisms remain poorly understood. In this study, we performed integrative transcriptomic analyses and identified glutaminase 1 (GLS1) as a key regulator of VSMC phenotypic switching in AD. GLS1 expression was significantly downregulated in VSMCs from both human AD aortic tissues and mouse models. Functionally, GLS1 deficiency promoted PDGF-BB–induced VSMC dedifferentiation in vitro. Smooth muscle cells specific Gls1 knockout (Gls1SMKO) mice exhibited aggravated AD upon BAPN treatment, whereas VSMCs specific GLS1 overexpression improved the contractile phenotype and reduced AD incidence. Mechanistically, GLS1 downregulation impaired glutamate metabolism, leading to reduced levels of glutathione and α-ketoglutarate. This metabolic disruption promoted reactive oxygen species accumulation and mitochondrial dysfunction, ultimately triggering VSMC phenotypic switching. Furthermore, we found that GLS1 transcription was repressed by retinoic acid receptor-α (RARα). Pharmacologic inhibition of RARα with AR7 restored GLS1 expression, ameliorated VSMC phenotypic switching, and conferred protection against AD. These findings reveal a critical role of GLS1-mediated glutamate metabolism in VSMC phenotypic switching and suggest a promising therapeutic strategy for AD.

Graphical Abstract
graphical abstract
Supplemental material

View

View Unedited blot and gel images

Version history
  • Version 1 (April 23, 2026): In-Press Preview

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Supplemental material
  • Version history
Advertisement
Advertisement

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts